Stay updated on Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.

Latest updates to the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry (v3.6.5) has been added to the history, indicating a recent update to the page. The previous revision (v3.6.4) is listed under deletions, suggesting it is no longer part of the current change set.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.6.4 replaced v3.6.3 in the page history, indicating a new version of the record was published.SummaryDifference0.1%

- Check37 days agoChange DetectedOn 2026-07-13, a Study Status entry was added to the record history to reflect the current status of the trial. On 2026-07-10, a numeric value 28 was added in the history, and a prior deletion on 2026-04-07 removed an earlier item from the history.SummaryDifference0.3%

- Check51 days agoChange DetectedThe history shows a new revision entry, Revision: v3.6.3, added to replace the previous Revision: v3.6.2.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history page shows a new Revision: v3.6.2 label replacing the prior v3.6.0, signaling a minor software update to the record history interface.SummaryDifference0.1%

- Check72 days agoChange DetectedThe history now shows 'No longer looking for participants' and adds Revision: v3.6.0, while removing Revision: v3.5.5. This reflects a recruitment status update and an updated version in the study record.SummaryDifference0.3%

Stay in the know with updates to Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab/Tremelumab ± Lenvatinib +TACE in HCC Clinical Trial page.